Dr. Christine Pratilas, MD
Claim this profileJohns Hopkins University/Sidney Kimmel Cancer Center
Studies Rhabdomyosarcoma
Studies Osteosarcoma
11 reported clinical trials
27 drugs studied
Area of expertise
1Rhabdomyosarcoma
FOXO1 fusion negative
Stage IV
FOXO1 fusion positive
2Osteosarcoma
H3 K27M positive
Stage IV
Affiliated Hospitals
Clinical Trials Christine Pratilas, MD is currently running
CBL0137
for Cancer
This trial tests CBL0137, a drug that blocks signals inside cancer cells, in patients whose solid tumors, including CNS tumors or lymphoma, have returned or not responded to treatment. By interfering with the cells' internal communication, the drug aims to stop their growth and cause them to die. CBL0137, also known as Curaxin, has shown antitumor activity in multiple cancers, including glioblastoma, renal cell carcinoma, melanoma, neuroblastoma, and small cell lung cancer.
Recruiting1 award Phase 1 & 213 criteria
Tiragolumab + Atezolizumab
for Solid Tumors
This trial studies how well tiragolumab and atezolizumab work in children and adults with difficult-to-treat tumors missing specific genes. These treatments help the immune system attack cancer and stop it from growing. Atezolizumab is an antibody that has been used with other treatments for various cancers.
Recruiting1 award Phase 1 & 214 criteria
More about Christine Pratilas, MD
Clinical Trial Related2 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Christine Pratilas, MD has experience with
- Cyclophosphamide
- Dactinomycin
- Vincristine
- Prednisone
- Mercaptopurine
- Methotrexate
Breakdown of trials Christine Pratilas, MD has run
Rhabdomyosarcoma
Osteosarcoma
Solid Tumors
Alveolar Rhabdomyosarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Christine Pratilas, MD specialize in?
Christine Pratilas, MD focuses on Rhabdomyosarcoma and Osteosarcoma. In particular, much of their work with Rhabdomyosarcoma has involved FOXO1 fusion negative patients, or patients who are Stage IV.
Is Christine Pratilas, MD currently recruiting for clinical trials?
Yes, Christine Pratilas, MD is currently recruiting for 4 clinical trials in Baltimore Maryland. If you're interested in participating, you should apply.
Are there any treatments that Christine Pratilas, MD has studied deeply?
Yes, Christine Pratilas, MD has studied treatments such as Cyclophosphamide, Dactinomycin, Vincristine.
What is the best way to schedule an appointment with Christine Pratilas, MD?
Apply for one of the trials that Christine Pratilas, MD is conducting.
What is the office address of Christine Pratilas, MD?
The office of Christine Pratilas, MD is located at: Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland 21287 United States. This is the address for their practice at the Johns Hopkins University/Sidney Kimmel Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.